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ABSTRACT
Current therapeutic treatment for anxiety is associated with a wild variety of side effects. The traditional use of plant extract to health care can 
indicate an important source of new pharmaceuticals. The present study was designed to evaluate the anxiolytic effect of Sarcostigma kleinii through 
the ethanolic extract of its aerial parts. The study duration was 5 days, and Swiss Albino mice were subjected to dosage of 400 mg/kg. The anxiolytic 
effect of the ethanolic extract was evaluated in light and dark, elevated plus maze, and stair case models. The ethanolic extract was effective in inducing 
anxiolytic effects when compared with the control group. Finally, neurotransmitters such as serotonin (5-HT) and gamma-aminobutyric acid (GABA) 
was estimated in mice brain. Decreased serotonin (5-HT) and increased level of GABA was observed in ethanolic extract, when compared with the 
control group. The alkaloids, flavonoids, and other chemical constituents are speculated to account for the observed pharmacological effects of the 
plant extract in the experimental animal paradigms used. These findings suggest that the ethanolic extract from the aerial parts of S. kleinii exhibits 
significant anxiolytic activity.
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INTRODUCTION
Human anxiety is defined as a feeling of apprehension, uncertainty 
or tension stemming from the anticipation of imagined or unreal 
threat [1]. Anxiety disorder is increasingly recognized as a highly 
prevalent and a chronic disorder with onset during the teenage years, 
with an incidence of 18.1% and in lifetime prevalence of 28.8%. 
The disorder is associated with a significant disability (including 
educational and occupational), which has a negative impact on the 
quality of life. Pharmacotherapeutic approaches for the management 
of anxiety disorders include psychotropic drugs, but these agents are 
limited by their side effects profile, the need for dietary precautions 
and drug interactions. Regular use of benzodiazepines causes 
deterioration of cognitive functioning, addiction, psychomotor 
impairment, confusion, aggression, excitement, anterograde amnesis, 
physical dependence and tolerance [2]. Numerous traditionally used 
plants exhibit pharmacological properties with great potential for 
therapeutic applications in the treatment of central nervous system 
disorders [3]. Sarcostigma klenii Wight and Arn (Icacinaceae) a large 
perennial woody climber grows up on large trees. Mainly found in 
sacred groves. The plant is also termed as odal, vellayodal, etc., plant 
possess various ayurvedic medicinal properties. Plant pacifies vitiated 
vata, arthritis, anorexia, worm infestation, skin diseases, hysteria, 
epilepsy, ulcers, and headache [4]. Based on the literature search, no 
study has been carried out to scientifically validate the folkloric uses of 
Sarcostigma kleinii Wight and Arn in the treatment of anxiety disorder. 
Hence, this study was carried out to investigate the anxiolytic effects of 
the S. kleinii Wight and Arn in mice and also the biochemical estimation 
of neurotransmitters in the anxiety state.
METHODS
Plant material
Collection and authentication of plant materials
Aerial parts of the plant S. kleinii Wight and Arn were collected from 
the place Pala, Kottayam district, Kerala during the month of February 
and authenticated by Asst. Prof. Rogimon P. Thomas, Department of 
Botany, C.M.S College, Kottayam, Kerala. The voucher specimens of the 
plant were kept in the library with register number DPS/MGU/RIMSR/
HERB7, for further reference.
Processing of sample
The aerial parts of the plant were collected, cleaned thoroughly with 
distilled water and the desired plant parts were dried under shade for 
30 days. The shade dried aerial parts were pulverized in a mechanical 
grinder to obtain coarse powder.
Preparation of extracts
The powdered plant was subjected to extraction by the soxhlet method 
using ethyl alcohol as a solvent. Evaporation of solvent from the extract 
was done by distillation method. A sticky mass were obtained after 
evaporation of the solvent. The samples were stored at 10°C till further 
use. At the time of administration, a suspension was prepared using the 
extract in 1% w/v of sodium carboxymethyl cellulose (sodium CMC).
Phytochemical analysis
Ethanolic extract of S. kleinii Wight and Arn
Ethanolic extract of S. kleinii Wight and Arn were subjected to 
preliminary phytochemical screening [5-7].
Experimental animals
Swiss Albino mice of either sex 20-30 g of body weight obtained from 
animal house, Department of Pharmacology, RIMSR, Kottayam. Animals 
were kept in standard animal house condition. Mice were housed in 
groups of six per cage. All the animals were maintained under standard 
conditions; that is room temperature 26±1°C, relative humidity 45-55% 
and 12:12 hrs light-dark cycle. The cages were maintained clean, and all 
experiments were conducted between 9 am and 4 pm.
Acute toxicity study
Female Swiss Albino mice (20-25 g weight) were used for acute oral 
toxicity study. The study was carried out as per the guidelines set by 
OECD 423 and animals were observed for mortality and behavioral 
changes [8].
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Ethical approval
The experimental protocols were approved by the Institutional Animal 
Ethics Committee (IAEC) of Regional Institute of Medical Sciences and 
Research Centre, Kottayam. (1702/po/c/06/CPCSEA2014) and all the 
experiments were conducted according to the guidelines of Committee 
for the Purpose of Control and Supervision of Experiments on Animals 
(CPCSEA).
Drugs and chemicals
Diazepam (Abbott Laboratory Limited), ethanol (Spectrum Chemicals), 
gamma-aminobutyric acid (GABA) (Sigma Aldrich), serotonin (Sigma 
Aldrich), O-phthaldialdehyde (OPT) (Hi Media), heptane (Spectrum 
Chemicals).
Pharmacological screening
Anxiolytic activity
Light and dark model
The apparatus consisted of a light and dark unit, consisting of a 
box with two distinct chambers, black and white, connected by a 
small open door way. The dark compartment (15 cm×40 cm) had 
its sidewalls and floor covered by a smooth black colored sun mica 
material. The bright compartment (40 cm×40 cm) had its side walls 
and floor covered by white colored sun mica material; it was brightly 
illuminated with a 60 W milky white bulb located 28 cm above the 
floor on the partition wall. An opening of (10 cm×10 cm) was located 
at a floor level in the center of the partition to allow access between 
two compartments for the animal [9]. Swiss albino mice (20-25 g) 
were taken and divided into three groups, each group comprised of 
six animals. Group A served as control and was administered with 1% 
sodium CMC, Group B with diazepam (2 mg/kg P.O) and served as a 
standard. Group C with extract (400 mg/kg P.O) for 5 days. On the 
5th day 1 hr after oral administration of 1% sodium CMC/standard/
extract to respective groups. Mouse is placed in the middle of the 
illuminated part of the cage.
The following parameters [10] are counted during 5 minutes period.
Percentage time spent in the light compartment was determined as 
follows:
% = 
100 × Number of seconds spent in light compartment
300 total seconds (5 minutes observation time
Elevated plus maze model
The apparatus consist of two open arms (5 cm×30 cm) and two closed 
arms (5 cm×15 cm×30 cm) radiating from a platform (5 cm×5 cm) to 
form a plus-sign figure. The apparatus was situated 40 cm above the 
floor. The open-arm edges were 1 cm in height to keep the mice from 
falling, and the closed-arm edges were 15 cm in height [11]. Swiss 
albino mice (20-25 g) were taken and divided into three groups, each 
group comprised of six animals. Group A served as control and was 
administered with 1% sodium CMC, Group B with diazepam (2 mg/kg 
P.O) and served as a standard. Group C with extract (400 mg/kg P.O) 
for 5 days. On the 5th day 1 hr after oral administration of 1% sodium 
CMC/standard/extract to respective groups. Animal was placed at the 
center facing the open arm. During 5 minutes test period the following 
measures [10] are taken:
Percentage time spent on the open arms was determined:
•	 Percentage	entries	in	open	arms	was	determined:
% = 
100 × Number of seconds spent on open arms
300 total seconds (5 minutes) observation time
•	 Percentage	entries	in	open	arms	was	determined:
% = 
100 × Number of open arms entries
Total entries in open and closed arms
Stair case model
Staircase consists of five identical steps 2 cm high, 10 cm wide and 
7.5 cm deep. The internal height of the walls is constant along the 
whole length of the staircase [12]. Swiss albino mice (20-25 g) were 
taken and divided into three groups, each group comprised of six 
animals. Group A served as control and was administered with 1% 
sodium CMC, Group B with diazepam (2 mg/kg P.O) and served as 
a standard. Group C with extract (400 mg/kg P.O) for 5 days. On the 
5th day 1 hr after oral administration of 1% sodium CMC/standard/
extract to respective groups. Then animal is placed on the floor of the 
box with its back to the staircase. The number of steps climbed and 
the number of rears are counted over a 3 minutes period. A step is 
considered to be climbed only if the mouse has placed all four paws 
on the step. After every observation, the box is cleaned in order to 
eliminate any olfactory cues, which might modify the behavior of the 
next animal.
•	 The	number	of	steps	climbed	and	the	number	of	rears	are	counted	
over a 3 minutes period.
Estimation of amino acids in the brain
Estimation of GABA
The level of GABA was estimated by multiple development paper 
chromatography method.
Experimental design
Swiss albino mice of either sex with body weight between 20 and 25 g 
were divided randomly into three groups of six animals each.
Group 1: Control; 1% sodium CMC (P.O)
Group 2: Standard; diazepam (2 mg/kg, P.O)
Group 3: EESK; (400 mg/kg, P.O).
All the treatment groups are pretreated with respective drug and 
dosage for 5 days. On the 5th day after oral administration of control/
standard/EESK was given 60 minutes prior to scarification of animals 
for ex-vivo studies.
Assay-procedure
1.0 ml of the supernatant from brain homogenate was evaporated to 
dryness at 70°C in an oven and the residue is reconstituted in 100 ml 
of distilled water. Standard solution of GABA at a concentration of 2 µM 
along with the sample is spotted on Whatman no. 1 chromatography 
paper using a micropipette. It was placed on a chamber containing 
butanol:acetic acid:water (12 v/v:3 v/v:5 v/v) as solvent. When the 
solvent front reached the top of the paper, it was removed and dried. 
A second run is performed similarly, after which the papers are dried 
sprayed with ninhydrin reagent and placed in an oven at 100°C for 
4 minutes. The portions, which carry GABA corresponding with the 
standard are cut and eluted with 0.005% CuSo4 in 75% ethanol. Their 
absorbance is read against blank at 515 nm in a spectrophotometer 
and using statistical analysis graph was plotted with corresponding 
values [13].
Estimation of serotonin
Experimental design
Swiss Albino mice of either sex with body weight between 20 and 25 g 
were divided randomly into three groups of six animals each.
Group 1: Control; 1% sodium CMC (P.O)
Group 2: Standard; diazepam (2 mg/kg, P.O)
Group 3: EESK; (400 mg/kg, P.O)
All the treatment groups are pretreated with respective drug and 
dosage for 5 days. On the 5th day after oral administration of control/
standard/EESK was given 60 minutes prior to scarification of animals 
for ex-vivo studies.
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Preparation of tissue extracts
On the day of the experiment mice were sacrificed, whole brain was 
dissected out and the sub-cortical region (including the striatum) 
was separated. Wet tissue was weight and was homogenized in 5 ml 
HCl-butanol for about 1 minute. The sample was then centrifuged for 
10 minutes at 2000 rpm. An aliquot supernatant phase (1 ml) was 
removed and added to centrifuge tube containing 2.5 ml heptane and 
0.31 ml HCl of 0.1 M. After 10 minutes of vigorous shaking, the tube was 
centrifuged under the same conditions as above in order to separate the 
two phases, and the overlaying organic phase was discarded. The aqueous 
phase (0.2 ml) was then taken for 5-HT. All steps were carried out at 0°C.
Assay
Reagents: OPT reagent: (20 mg in 100 ml conc. HCl)
Procedure
To 0.2 ml, aqueous extract 0.25 ml of OPT reagent was added. The 
fluorophore was developed by heating to 100°C for 10 minutes. After 
the samples reached equilibrium with the ambient temperature, 
readings were taken at 360-470 nm in the spectrofluorimeter. Tissue 
blank were prepared by adding, 0.25 ml conc. HCI without OPT reagent. 
Internal standard: (500 µg/ml of serotonin are prepared in distilled 
water) HCl - butanol in 1:2 ratio [14].
Statistical analysis
All data were represented as mean±standard error mean values. Data 
were analyzed by one-way ANOVA. Whenever ANOVA was significant, 
further comparison was made against the vehicle treated groups were 
performed using the Dunnett’s - tests.
RESULTS
Acute toxicity
Acute toxicity study for EESK was performed according to OECD guidelines 
423 using female Swiss Albino mice. At 2000 mg/kg, the extract was 
neither produced mortality nor the signs of morbidity. Hence, the dose 
400 mg/kg (1/5th of 2000 mg/kg) was selected for further studies.
Phytochemical analysis
The results of the chemical tests performed in the screening revealed the 
presences of flavonoids, alkaloids, tannins, carbohydrates, glycosides in 
the ethanolic extract of aerial parts of S. kleinii Wight and Arn (Table 1).
Assessment of anxiolytic activity
Light and dark model
In light and dark model, the ethanolic extract of aerial parts of S. kleinii 
at a dose of 400 mg/kg P.O and standard drug diazepam 2 mg/kg P.O, 
significantly increased the percentage of time spent in light side, when 
compared to control group (Fig. 1).
Elevated plus maze model
The ethanolic extract of aerial parts of S. kleinii at a dose (400 mg/kg 
P.O) and standard drug (diazepam 2 mg/kg P.O). Significantly increased 
the percentage time and percentage of entries into open arms as 
compared to the control group (Figs. 2 and 3).
Stair case model
The ethanolic extract of S. kleinii 400 mg/kg, P.O, and standard drug 
(diazepam 2 mg/kg, P.O) both were significantly reduced the number 
of rearing as well as the number of steps climbed, when compared to 
control (1% CMC) (Fig. 4).
Ex-vivo methods
Estimation of GABA in mice brain
The ethanolic extract of S. kleinii 400 mg/kg, P.O, and standard drug 
(diazepam 2 mg/kg, P.O) showed a significant increase in the GABA 
level, when compared to control (1% CMC) and the caliberation curve 
shows linearity (Table 2 and Fig. 5). 
Estimation of serotonin in mice brain   
The ethanolic extract of S. kleinii 400 mg/kg, P.O, and standard drug 
(diazepam 2 mg/kg, P.O) showed a significant decrease in the serotonin 
level, when compared to control (1% CMC) and the caliberation curve 
shows linearity (Table 3 and Fig. 6). 
DISCUSSION
Transitions have been reported to be an index of activity exploration 
because of habituation overtime and the time spent in each 
compartment to be a reflection of aversion. The percentage of 
Table 1: Phytochemical analysis of aerial parts of S. kleinii
Phytochemicals Ethanolic extract
Flavonoids +
Alkaloids +
Tannins +
Phenols +
Glycosides +
Triterpenoids +
Amino acids −
Saponins −
“+”	Indicates	presence,	and	“−”	indicates	absences	of	the	phytochemical	
constituents. S. kleinii: Sarcostigma kleinii
Table 3: Effect of ethanolic extract of S. kleinii (400 mg/kg) 
and standard drug diazepam (2 mg/kg) showed a significant 
decrease in serotonin level in the mice brains
S.No Treatment group Amount of serotonin 
in µg/g of Ww tissue
1. Control (1% CMC) 0.13±0.006
2. Standard (diazepam 2 mg/kg) 0.013±0.0018**
3. EESK 400 mg/kg (day 5) 0.056±0.0048**
*p<0.05, **p<0.01, when compared to control. CMC: Carboxy methyl cellulose, 
S. kleinii: Sarcostigma kleinii 
Table 2: Effect of ethanolic extract of S. kleinii (400 mg/kg) 
showed significant increase in the GABA level in the mice brain, 
diazepam (2 mg/kg) showed more significant increase in the 
GABA levels in the brain
S.No Treatment group Amount of GABA in 
µg/g of Ww tissue
1 Control (1% CMC) 14.3±0.51
2 Standard (diazepam 2 mg/kg) 58.6±1.36∗∗
3 EESK 400 mg/kg 35.1±0.98**
*p<0.05, **p<0.01, when compared to control. GABA: Gamma-aminobutyric 
acid, S. kleinii: Sarcostigma kleinii
Fig. 1: Effect of ethanolic extract of Sarcostigma kleinii 
(400 mg/kg) and standard (diazepam 2 mg/kg) on percentage 
time spent by the mice on light area in light and dark model, 
*p<0.05, **p<0.01 when compared to control
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time spent in the lit compartment is an index of the anxiety-related 
behavior. Anxiety is considered to be high if the percentage of time 
spent in the lit compartment is low. Following repeated administration 
of ethanolic extract of S. kleinii significantly increased the percentage 
time spent in the lit compartment, compared to the control group. 
The sub-chronic administration of EESK, in the elevated plus-maze 
test-induced an increase in the exploration and the percentage 
time spent (i.e. anxiolytic-like action) and the percentage number 
of entries into the open arms did not changed by the oral treatment 
with the EESK in comparison to the control values. The elevated 
plus-maze is a well-accepted, experimental animal model typically 
used to test the effectiveness of anxiolytics drugs. When animal 
introduced into a novel environment, rodents experience a conflict 
between anxiety and exploratory behavior manifested by increased 
vigilance and behavioral activity. In the staircase paradigm, step 
climbing is purported to reflect exploratory or locomotor activity or 
sedative activity while rearing behavior is an index of anxiety state. 
The present investigation successfully detected the anxiolytic-like 
effects of repeated administration of ethanolic extract of S. kleinii and 
diazepam both significantly decreased the number of rearing, and 
number of steps climbed, compared to control. The neurotransmitters 
such as GABA, and serotonin involved in the development of anxiety 
disorders. Estimation of GABA levels by multiple development paper 
chromatography follows that the principle of different partition 
coefficients that can be obtained from a stationary cellulose phase 
with a mobile solvent phase for different amino acids, which aid in 
their separation. Ethanolic extract of S. kleinii and standard drug 
diazepam (2 mg/kg) showed a significant increase in the GABA level 
in the brain when compared with the control animals. Estimation of 
serotonin by the spectrofluorometric method discuss that activation 
and fluorescence spectra derived from 5-HT was described by the 
formation of 5-HT - OPT complex. Ethanolic extract of S. kleinii 
(400 mg/kg) and standard drug diazepam (2 mg/kg) showed a 
significant decrease in the serotonin level in the brain when compared 
with the control animals.
CONCLUSION
The chemical investigation of the plant was not able to identify specific 
bioactive compounds, but the phytochemical group was associated with 
the medicinal effects. It can be tannins, alkaloids, flavonoids, terpenoids 
and glycosides. Many of these phytochemical groups are known 
individually to have specific health benefits. Based on these, the effect 
of ethanolic extract of S. kleinii was studied in different animal models. 
The results of the work provided evidence that the ethanolic extract 
Fig. 2: Effect of ethanolic extract of Sarcostigma kleinii 
(400 mg/kg) and standard (diazepam 2 mg/kg) on percentage 
time spent by the mice in open arm in elevated plus maze, 
*p<0.05, **p<0.01 when compared to control
Fig. 3: Effect of ethanolic extract of Sarcostigma kleinii 
(400 mg/kg) and standard (diazepam 2 mg/kg), percentage 
entries into open arms by the mice in elevated plus maze, *p<0.05, 
**p<0.01 when compared to control
Fig. 4: Effect of ethanolic extract of Sarcostigma kleinii 
(400 mg/kg) and standard (diazepam 2 mg/kg) on number 
climbing and rearing by the mice in stair case apparatus, *p<0.05, 
**p<0.01 when compared to control
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Fig. 6: The calibration curve for serotonin with concentration 
against fluorescence intensity a linear graph was plotted
Fig. 5: The calibration curve for gamma-aminobutyric acid was 
plotted with concentration against absorbance at 550 nm
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of S. kleinii may contain phytoconstituents that can suppress anxiety. 
Thus, S. kleinii may be a promising candidate for future development as 
a new anxiolytic drug.
REFERENCES
1. Kulkarni SK, Reddy DS. Animal behavioral models for 
testing antianxiety agents. Methods Find Exp Clin Pharmacol 
1996;18(3):219-30.
2. Suresh K, Anupam S. Apigenin. The anxiolytic constituent of Tumera 
aphrodisiaca. Pharm Biol 2006;44:84-90.
3. Carlini EA. Plants and the central nervous system. Pharmacol Biochem 
Behav 2003;75:501-12.
4. Warrier PK, Nambiar VP, Ramankutty C. Indian Medicinal Plants A 
Compendium of Species. Vol. 5. Hyderabad: Orient Longman; 1993. 
p. 76-9.
5. Kokate CK, Purohit AP, Gokhale SB. Pharmacognosy. 29th ed. Pune: 
Nirali Prakasan; 2005. p. 225.
6. Mukherjee PK. Qualitative analysis of plant extract for phytochemical 
constituents. Pharmacognosy. 1st ed. Horizon Pharmaceutical 
Publishers; 2002.
7. Evan WC. Trease and Evans Pharmacognosy. 14th ed. India: Harcourt 
Brace and Company; 1998.
8. OECD Guideline 423, for Testing of Chemicals. Acute Oral Toxicity – 
Acute Toxic Class Method. December, 2001.
9. Ankitkumar A, Ashok M, Jyothsna V, Radhakrishna B, Gowda KP. 
Evaluation of anxiolytic activity of aqueous and alcoholic extracts 
of leaves of Crataegus oxycantha in mice. Int J Pharm Biomed Sci 
2008;2(3):86-9.
10. Gilhotra N, Dhingra D. Possible involvement of GABAergic and 
nitriergic systems for antianxiety-like activity of piperine in unstressed 
and stressed mice. Pharmacol Rep 2014;66(5):885-91.
11. Baretta IP, Felizardo RA, Bimbato VF, dos Santos MG, Kassuya CA, 
Gasparotto Junior A, et al. Anxiolytic-like effects of acute and chronic 
treatment with Achillea millefolium L. extract. J Ethnopharmacol 
2012;140(1):46-54.
12. Kavya Sree K, Vijusha M, Rajani A, Hemamalini K. Screening 
of behavioural, muscle co-ordination and anxiolytic activities of 
methanolic extract of Holoptelea integrifolia (ROXB). Int Res J Pharm 
2013;4(11):90-4.
13. Rahman H, Muralidharan P, Anand M. Inhibition of AChE and 
antioxidant activities are probable mechanism of Nardostacys jatamansi 
DC in sleep deprived Alzheimer’s mice model. Int J Pharm Technol Res 
2011;3(3):1807-16.
14. Curzon G, Green AR. A rapid and sensitive method for measuring 
5-hydroxytryptamine and 5-hydroxyindoleacetic acid, using 
O-phthaldehyde and L-cysteine, is presented, enabling both compounds 
to be measured in small areas of rat brain. Br J Pharm 1970;39:653-5.
